$0.0764
0.005407.61%
At close: -
Comments
Loading...
Rafarma Pharma Analyst Ratings and Price Targets | OTC:RAFA | Benzinga
Rafarma Pharma Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Rafarma Pharma Corp from these most-recent analyst ratings.
Analyst Ratings for Rafarma Pharma
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Rafarma Pharma (RAFA) stock?
There is no price target for Rafarma Pharma
What is the most recent analyst rating for Rafarma Pharma (RAFA)?
There is no analyst for Rafarma Pharma
When was the last upgrade for Rafarma Pharma (RAFA)?
There is no last upgrade for Rafarma Pharma
When was the last downgrade for Rafarma Pharma (RAFA)?
There is no last downgrade for Rafarma Pharma.
When is the next analyst rating going to be posted or updated for Rafarma Pharma (RAFA)?
There is no next analyst rating for Rafarma Pharma.
Is the Analyst Rating Rafarma Pharma (RAFA) correct?
There is no next analyst rating for Rafarma Pharma.
Browse analyst ratings and price targets on all stocks.
